Zdrowie i gospodarka · 07/05/2014

FDA Releases Draft Guidance for Industry on Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Treatment Development

The Food and Drug Administration (FDA) has released a draft guidance for industry on developing antibacterial drugs for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. The guidance aims to assist clinical trial sponsors and investigators in designing clinical trials based on the latest scientific understanding of the disease.